series-c-plus
Stage
1
Investors
About
SetPoint Medical develops implantable neuromodulation devices that deliver targeted vagus nerve stimulation to modulate the immune system and treat chronic inflammatory and autoimmune diseases such as rheumatoid arthritis and Crohn's disease.
Explore SetPoint Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.